59961-15-8 Usage
General Description
3-Bromomethyl-thiophene-2-carboxylic acid methyl ester is a chemical compound that belongs to the group of thiophene carboxylic esters; a subclass of thiophenes. Thiophenes are five-membered heterocyclic compounds that consist of four carbon atoms and a sulfur atom. Typically used in the field of organic synthesis, 3-Bromomethyl-thiophene-2-carboxylic acid methyl ester is an important chemical molecule found useful in a variety of chemical reactions due to its bromomethyl functional group and carboxylic ester group. It has a molecular formula of C7H7BrO2S, however, its safety and detailed physical properties are usually supplier-specific and should be accessed through specific Material Safety Data Sheets (MSDS).
Check Digit Verification of cas no
The CAS Registry Mumber 59961-15-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,9,9,6 and 1 respectively; the second part has 2 digits, 1 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 59961-15:
(7*5)+(6*9)+(5*9)+(4*6)+(3*1)+(2*1)+(1*5)=168
168 % 10 = 8
So 59961-15-8 is a valid CAS Registry Number.
InChI:InChI=1/C7H7BrO2S/c1-10-7(9)6-5(4-8)2-3-11-6/h2-3H,4H2,1H3
59961-15-8Relevant articles and documents
METHODS OF TREATING NEURODEGENERATIVE DISEASES
-
Paragraph 0194, (2020/03/23)
Described herein are methods of treating or preventing an ASK1 or DYRK1A associated disease, disorder, or condition comprising administering to a subject in need thereof a dual inhibitor of ASK1 and DYRK1A; including administering pharmaceutically acceptable salts and solvates thereof.
New tetracyclic compound
-
Paragraph 0393-0397, (2019/11/14)
The invention relates to a new tetracyclic compound. The tetracyclic compound has a structure shown in the formula (III) and can be used as a bromine domain and additional terminal (BET) inhibitor. The invention further relates to synthesis and application of the compounds in disease treatment. More specifically, the invention relates to a fused heterocyclic derivative used as a BET inhibitor, a method for the preparation of these compounds, and a disease and symptom treatment method conductive to inhibition of one or more BET bromine domains.
HETEROARYL COMPOUNDS AS BTK INHIBITORS AND USES THEREOF
-
Paragraph 0512, (2016/05/02)
The present invention relates to imidazo pyridine compounds, and pharmaceutically acceptable compositions thereof, useful as BTK inhibitors.
